Treatment of common variable immune deficiency

Bibliography

• Al-Herz W, Bousfiha A, Casanova JL, Primary immunodeficiency diseases: an update on the classification from the international union of immunological societies expert committee for primary immunodeficiency. Front Immunol 2011;2:54
   PubMed Web of Science ®Google Scholar
• Conley ME, Notarangelo LD, Etzioni A. Diagnostic criteria for primary immunodeficiencies. Representing PAGID (Pan-American Group for Immunodeficiency) and ESID (European Society for Immunodeficiencies). Clin Immunol 1999;93(3):190-7
   PubMed Web of Science ®Google Scholar
• Chapel H, Cunningham-Rundles C. Update in understanding common variable immunodeficiency disorders (CVIDs) and the management of patients with these conditions. Br J Haematol 2009;145(6):709-27
   PubMed Web of Science ®Google Scholar
• Janeway CA, Apt L, Gitlin D. Agammaglobulinemia. Trans Assoc Am Physicians 1953;66:200-2
   PubMedGoogle Scholar
• Resnick ES, Moshier EL, Godbold JH, Cunningham-Rundles C. Morbidity and mortality in common variable immune deficiency over 4 decades. Blood 2012;119(7):1650-7
   PubMed Web of Science ®Google Scholar
• Cunningham-Rundles C, Bodian C. Common variable immunodeficiency: clinical and immunological features of 248 patients. Clin Immunol 1999;92(1):34-48
   PubMed Web of Science ®Google Scholar
• Cunningham-Rundles C. How I treat common variable immune deficiency. Blood 2010;116(1):7-15
   PubMed Web of Science ®Google Scholar
• Agematsu K, Hokibara S, Nagumo H, Plasma cell generation from B-lymphocytes via CD27/CD70 interaction. Leuk Lymphoma 1999;35(3-4):219-25
   PubMed Web of Science ®Google Scholar
• Warnatz K, Denz A, Drager R, Severe deficiency of switched memory B cells (CD27(+)IgM(-)IgD(-)) in subgroups of patients with common variable immunodeficiency: a new approach to classify a heterogeneous disease. Blood 2002;99(5):1544-51
   PubMed Web of Science ®Google Scholar
• Ochtrop ML, Goldacker S, May AM, T and B lymphocyte abnormalities in bone marrow biopsies of common variable immunodeficiency. Blood 2011;118(2):309-18
   PubMed Web of Science ®Google Scholar
• Park JH, Resnick ES, Cunningham-Rundles C. Perspectives on common variable immune deficiency. Ann N Y Acad Sci 2011;1246:41-9
   PubMed Web of Science ®Google Scholar
• Yong PF, Thaventhiran JE, Grimbacher B. "A rose is a rose is a rose," but CVID is Not CVID common variable immune deficiency (CVID), what do we know in 2011? Adv Immunol 2011;111:47-107
   PubMed Web of Science ®Google Scholar
• van der Burg M, van Zelm MC, Driessen GJ, van Dongen JJ. New frontiers of primary antibody deficiencies. Cell Mol Life Sci 2012;69(1):59-73
   PubMed Web of Science ®Google Scholar
• Resnick ES, Cunningham-Rundles C. The many faces of the clinical picture of common variable immune deficiency. Curr Opin Allergy Clin Immunol 2012;12(6):595-601
   PubMed Web of Science ®Google Scholar
• Salzer U, Warnatz K, Peter HH. Common variable immunodeficiency - an update. Arthritis Res Ther 2012;14(5):223
   PubMed Web of Science ®Google Scholar
• Chapel H, Lucas M, Lee M, Common variable immunodeficiency disorders: division into distinct clinical phenotypes. Blood 2008;112(2):277-86
   PubMed Web of Science ®Google Scholar
• Malphettes M, Gerard L, Carmagnat M, Late-onset combined immune deficiency: a subset of common variable immunodeficiency with severe T cell defect. Clin Infect Dis 2009;49(9):1329-38
   PubMed Web of Science ®Google Scholar
• van Assen S, de Haan A, Holvast A, Cell-mediated immune responses to inactivated trivalent influenza-vaccination are decreased in patients with common variable immunodeficiency. Clin Immunol 2011;141(2):161-8
   Google Scholar
• Kuntz M, Goldacker S, Blum HE, Analysis of bulk and virus-specific CD8+ T cells reveals advanced differentiation of CD8+ T cells in patients with common variable immunodeficiency. Clin Immunol 2011;141(2):177-86
   PubMed Web of Science ®Google Scholar
• Lopez-Boado YS, Rubin BK. Macrolides as immunomodulatory medications for the therapy of chronic lung diseases. Curr Opin Pharmacol 2008;8(3):286-91
   PubMed Web of Science ®Google Scholar
• Orange JS, Hossny EM, Weiler CR, Use of intravenous immunoglobulin in human disease: a review of evidence by members of the Primary Immunodeficiency Committee of the American Academy of Allergy, Asthma and Immunology. J Allergy Clin Immunol 2006;117(4 Suppl):S525-53
   PubMed Web of Science ®Google Scholar
• Abolhassani H, Sadaghiani MS, Aghamohammadi A, Home-Based Subcutaneous Immunoglobulin Versus Hospital-Based Intravenous Immunoglobulin in Treatment of Primary Antibody Deficiencies: systematic Review and Meta Analysis. J Clin Immunol 2012;
   Google Scholar
• Schroeder HW Jr, Dougherty CJ. Review of intravenous immunoglobulin replacement therapy trials for primary humoral immunodeficiency patients. Infection 2012;40(6):601-11
   Google Scholar
• Kaveri SV, Maddur MS, Hegde P, Intravenous immunoglobulins in immunodeficiencies: more than mere replacement therapy. Clin Exp Immunol 2011;164(Suppl 2):2-5
   PubMed Web of Science ®Google Scholar
• Rezaei N, Abolhassani H, Aghamohammadi A, Ochs HD. Indications and safety of intravenous and subcutaneous immunoglobulin therapy. Expert Rev Clin Immunol 2011;7(3):301-16
   PubMed Web of Science ®Google Scholar
• Haddad E, Barnes D, Kafal A. Home therapy with subcutaneous immunoglobulins for patients with primary immunodeficiency diseases. Transfus Apher Sci 2012;46(3):315-21
   PubMed Web of Science ®Google Scholar
• Busse PJ, Razvi S, Cunningham-Rundles C. Efficacy of intravenous immunoglobulin in the prevention of pneumonia in patients with common variable immunodeficiency. J Allergy Clin Immunol 2002;109(6):1001-4
   PubMed Web of Science ®Google Scholar
• de Gracia J, Vendrell M, Alvarez A, Immunoglobulin therapy to control lung damage in patients with common variable immunodeficiency. Int Immunopharmacol 2004;4(6):745-53
   PubMed Web of Science ®Google Scholar
• Orange JS, Belohradsky BH, Berger M, Evaluation of correlation between dose and clinical outcomes in subcutaneous immunoglobulin replacement therapy. Clin Exp Immunol 2012;169(2):172-81
   PubMed Web of Science ®Google Scholar
• Roifman CM, Levison H, Gelfand EW. High-dose versus low-dose intravenous immunoglobulin in hypogammaglobulinaemia and chronic lung disease. Lancet 1987;1(8541):1075-7
   PubMed Web of Science ®Google Scholar
• Eijkhout HW, van Der Meer JW, Kallenberg CG, The effect of two different dosages of intravenous immunoglobulin on the incidence of recurrent infections in patients with primary hypogammaglobulinemia. A randomized, double-blind, multicenter crossover trial. Ann Intern Med 2001;135(3):165-74
   PubMed Web of Science ®Google Scholar
• Berger M. Incidence of infection is inversely related to steady-state (trough) serum IgG level in studies of subcutaneous IgG in PIDD. J Clin Immunol 2011;31(5):924-6
   PubMed Web of Science ®Google Scholar
• Lucas M, Lee M, Lortan J, Infection outcomes in patients with common variable immunodeficiency disorders: relationship to immunoglobulin therapy over 22 years. J Allergy Clin Immunol 2010;125(6):1354-60; e4
   PubMed Web of Science ®Google Scholar
• Bondioni MP, Soresina A, Lougaris V, Common variable immunodeficiency: computed tomography evaluation of bronchopulmonary changes including nodular lesions in 40 patients. Correlation with clinical and immunological data. J Comput Assist Tomogr 2010;34(3):395-401
   Google Scholar
• Bonagura VR, Marchlewski R, Cox A, Rosenthal DW. Biologic IgG level in primary immunodeficiency disease: the IgG level that protects against recurrent infection. J Allergy Clin Immunol 2008;122(1):210-12
   PubMed Web of Science ®Google Scholar
• Park JH, Levinson AI. Granulomatous-lymphocytic interstitial lung disease (GLILD) in common variable immunodeficiency (CVID). Clin Immunol 2009;134(2):97-103
   Google Scholar
• Cunningham-Rundles C. Common variable immunodeficiency. Curr Allergy Asthma Rep 2001;1(5):421-9
   PubMedGoogle Scholar
• Palanduz S, Palanduz A, Yalcin I, In vitro chromosomal radiosensitivity in common variable immune deficiency. Clin Immunol Immunopathol 1998;86(2):180-2
   Google Scholar
• Serra G, Milito C, Mitrevski M, Lung MRI as a possible alternative to CT scan for patients with primary immune deficiencies and increased radiosensitivity. Chest 2011;140(6):1581-9
   PubMed Web of Science ®Google Scholar
• Mechanic LJ, Dikman S, Cunningham-Rundles C. Granulomatous disease in common variable immunodeficiency. Ann Intern Med 1997;127(8 Pt 1):613-17
   PubMed Web of Science ®Google Scholar
• Ardeniz O, Cunningham-Rundles C. Granulomatous disease in common variable immunodeficiency. Clin Immunol 2009;133(2):198-207
   PubMed Web of Science ®Google Scholar
• Bates CA, Ellison MC, Lynch DA, Granulomatous-lymphocytic lung disease shortens survival in common variable immunodeficiency. J Allergy Clin Immunol 2004;114(2):415-21
   PubMed Web of Science ®Google Scholar
• Wheat WH, Cool CD, Morimoto Y, Possible role of human herpesvirus 8 in the lymphoproliferative disorders in common variable immunodeficiency. J Exp Med 2005;202(4):479-84
   PubMed Web of Science ®Google Scholar
• Boursiquot JN, Gerard L, Malphettes M, Granulomatous Disease in CVID: retrospective Analysis of Clinical Characteristics and Treatment Efficacy in a Cohort of 59 Patients. J Clin Immunol 2012
   Google Scholar
• Davies CW, Juniper MC, Gray W, Lymphoid interstitial pneumonitis associated with common variable hypogammaglobulinaemia treated with cyclosporin A. Thorax 2000;55(1):88-90
   PubMedGoogle Scholar
• Aukrust P, Lien E, Kristoffersen AK, Persistent activation of the tumor necrosis factor system in a subgroup of patients with common variable immunodeficiency–possible immunologic and clinical consequences. Blood 1996;87(2):674-81
   PubMed Web of Science ®Google Scholar
• Mullighan CG, Fanning GC, Chapel HM, Welsh KI. TNF and lymphotoxin-alpha polymorphisms associated with common variable immunodeficiency: role in the pathogenesis of granulomatous disease. J Immunol 1997;159(12):6236-41
   PubMed Web of Science ®Google Scholar
• Thatayatikom A, Thatayatikom S, White AJ. Infliximab treatment for severe granulomatous disease in common variable immunodeficiency: a case report and review of the literature. Ann Allergy Asthma Immunol 2005;95(3):293-300
   PubMed Web of Science ®Google Scholar
• Lin JH, Liebhaber M, Roberts RL, Etanercept treatment of cutaneous granulomas in common variable immunodeficiency. J Allergy Clin Immunol 2006;117(4):878-82
   PubMed Web of Science ®Google Scholar
• Malbran A, Juri MC, Fernandez Romero DS. Common variable immunodeficiency and granulomatosis treated with infliximab. Clin Immunol 2010;134(3):359-60
   Google Scholar
• Chase NM, Verbsky JW, Hintermeyer MK, Use of Combination Chemotherapy for Treatment of Granulomatous and Lymphocytic Interstitial Lung Disease (GLILD) in Patients with Common Variable Immunodeficiency (CVID). J Clin Immunol 2012; [Epub ahead of print]
   Google Scholar
• Quinti I, Soresina A, Spadaro G, Long-term follow-up and outcome of a large cohort of patients with common variable immunodeficiency. J Clin Immunol 2007;27(3):308-16
   PubMed Web of Science ®Google Scholar
• Wang J, Cunningham-Rundles C. Treatment and outcome of autoimmune hematologic disease in common variable immunodeficiency (CVID). J Autoimmun 2005;25(1):57-62
   PubMed Web of Science ®Google Scholar
• Gobert D, Bussel JB, Cunningham-Rundles C, Efficacy and safety of rituximab in common variable immunodeficiency-associated immune cytopenias: a retrospective multicentre study on 33 patients. Br J Haematol 2011;155(4):498-508
   PubMed Web of Science ®Google Scholar
• Seve P, Bourdillon L, Sarrot-Reynauld F, Autoimmune hemolytic anemia and common variable immunodeficiency: a case-control study of 18 patients. Medicine (Baltimore) 2008;87(3):177-84
   PubMed Web of Science ®Google Scholar
• Hermaszewski RA, Webster AD. Primary hypogammaglobulinaemia: a survey of clinical manifestations and complications. Q J Med 1993;86(1):31-42
   PubMedGoogle Scholar
• Kinlen LJ, Webster AD, Bird AG, Prospective study of cancer in patients with hypogammaglobulinaemia. Lancet 1985;1(8423):263-6
   PubMed Web of Science ®Google Scholar
• Dhalla F, da Silva SP, Lucas M, Review of gastric cancer risk factors in patients with common variable immunodeficiency disorders, resulting in a proposal for a surveillance programme. Clin Exp Immunol 2011;165(1):1-7
   PubMed Web of Science ®Google Scholar
• Rezaei N, Hedayat M, Aghamohammadi A, Nichols KE. Primary immunodeficiency diseases associated with increased susceptibility to viral infections and malignancies. J Allergy Clin Immunol 2011;127(6):1329-41; e2; quiz 42-3
   PubMed Web of Science ®Google Scholar
• da Silva SP, Resnick E, Lucas M, Lymphoid proliferations of indeterminate malignant potential arising in adults with common variable immunodeficiency disorders: unusual case studies and immunohistological review in the light of possible causative events. J Clin Immunol 2011;31(5):784-91
   Google Scholar
• Agarwal S, Mayer L. Pathogenesis and treatment of gastrointestinal disease in antibody deficiency syndromes. J Allergy Clin Immunol 2009;124(4):658-64
   Google Scholar
• Daniels JA, Lederman HM, Maitra A, Montgomery EA. Gastrointestinal tract pathology in patients with common variable immunodeficiency (CVID): a clinicopathologic study and review. Am J Surg Pathol 2007;31(12):1800-12
   PubMed Web of Science ®Google Scholar
• Chua I, Standish R, Lear S, Anti-tumour necrosis factor-alpha therapy for severe enteropathy in patients with common variable immunodeficiency (CVID). Clin Exp Immunol 2007;150(2):306-11
   PubMed Web of Science ®Google Scholar
• Ward C, Lucas M, Piris J, Abnormal liver function in common variable immunodeficiency disorders due to nodular regenerative hyperplasia. Clin Exp Immunol 2008;153(3):331-7
   PubMed Web of Science ®Google Scholar
• Reyes J, Todo S, Green M, Graft-versus-host disease after liver and small bowel transplantation in a child. Clin Transplant 1997;11(5 Pt 1):345-8
   Google Scholar
• Burton CM, Milman N, Andersen CB, Common variable immune deficiency and lung transplantation. Scand J Infect Dis 2007;39(4):362-7
   PubMed Web of Science ®Google Scholar
• Murakawa Y, Miyagawa-Hayashino A, Ogura Y, Liver transplantation for severe hepatitis in patients with common variable immunodeficiency. Pediatr Transplant 2012;16(6):E210-16
   Google Scholar
• Shovlin CL, Simmonds HA, Fairbanks LD, Adult onset immunodeficiency caused by inherited adenosine deaminase deficiency. J Immunol 1994;153(5):2331-9
   PubMedGoogle Scholar
• Rizzi M, Neumann C, Fielding AK, Outcome of allogeneic stem cell transplantation in adults with common variable immunodeficiency. J Allergy Clin Immunol 2011;128(6):1371-4; e2
   PubMed Web of Science ®Google Scholar